StockNews.com Initiates Coverage on Athersys (NASDAQ:ATHX)
Stock analysts at StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Athersys Stock Performance The company has a market cap of $833,000.00, a price-to-earnings ratio of -0.01 and a […]
Stock analysts at StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Athersys Stock Performance The company has a market cap of $833,000.00, a price-to-earnings ratio of -0.01 and a […]
-corp-logo-1200x675.jpg?v=20231005103726&w=240&h=240&zc=2){kind=logo}
